Literature DB >> 21388447

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

R Pfister1, R Cairns, E Erdmann, C A Schneider.   

Abstract

AIMS: Although a resting electrocardiograph is broadly applied in clinical practice for evaluating patients with Type 2 diabetes and cardiovascular disease, the independent prognostic relevance of electrocardiographic signs has not thoroughly been examined.
METHODS: Baseline 12-lead electrocardiographs available in 5231 of the 5238 participants of the PROactive trial were analysed for heart rate, heart rate corrected QT-interval, presence of atrial fibrillation/flutter, left axis deviation, right and left bundle branch block. The association of electrocardiographic signs with total mortality, the principal secondary composite endpoint (death, myocardial infarction and stroke) and serious adverse heart failure events was examined by Cox-regression analysis.
RESULTS: Two hundred and twenty-three (4.3%) patients showed atrial fibrillation/flutter, 213 (4.1%) patients had right bundle branch block, 111 (2.1%) patients had left bundle branch block and 706 (13.5%) patients had left axis deviation. Mean cQT-interval was 418 ms (± 25 ms) and mean heart rate was 72/min (± 14/min). In multivariate adjusted analyses, heart rate and cQT-interval were significantly associated with mortality, the composite secondary endpoint and heart failure, whereas right and left bundle branch blocks were significantly associated with heart failure only. Left axis deviation was associated with heart failure and atrial fibrillation/flutter was associated with mortality and heart failure in univariate but not multivariate analyses.
CONCLUSION: Easily assessable electrocardiographic signs such as heart rate, cQT-interval and bundle branch blocks were predictive for adverse outcome independently of multiple risk factor adjustment and should be considered in clinical care.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Year:  2011        PMID: 21388447     DOI: 10.1111/j.1464-5491.2011.03281.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

Review 1.  Structural changes in the myocardium during diabetes-induced cardiomyopathy.

Authors:  Ernest Adeghate; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review.

Authors:  Markolf Hanefeld; Eva Duetting; Peter Bramlage
Journal:  Cardiovasc Diabetol       Date:  2013-09-21       Impact factor: 9.951

3.  Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction.

Authors:  Hamid Reza Bonakdar; Masoumeh Aslanpour; Hassan Moladoust; Parham Sadeghipour; Fereshteh Mohamadi; Mohammad Assadian Rad; Jalal Kheirkhah
Journal:  J Tehran Heart Cent       Date:  2014-07-06

4.  Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats.

Authors:  Fatma Mostafa; Adel Abdel-Moneim; Manal Abdul-Hamid; Sanaa R Galaly; Hanaa M Mohamed
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

5.  Molecular and Electrophysiological Role of Diabetes-Associated Circulating Inflammatory Factors in Cardiac Arrhythmia Remodeling in a Metabolic-Induced Model of Type 2 Diabetic Rat.

Authors:  Julian Zayas-Arrabal; Amaia Alquiza; Erkan Tuncay; Belma Turan; Monica Gallego; Oscar Casis
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

6.  Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.

Authors:  Xi Fu; Yilong Pan; Qian Cao; Bin Li; Shuo Wang; Hongjiao Du; Na Duan; Xiaodong Li
Journal:  BMC Cardiovasc Disord       Date:  2018-04-10       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.